Evidence map›Paper›PMID 33461384›Full record

ArticleAutophagy2021

Autophagy activation, lipotoxicity and lysosomal membrane permeabilization synergize to promote pimozide- and loperamide-induced glioma cell death.

Nina Meyer, Lisa Henkel, Benedikt Linder, Svenja Zielke, Georg Tascher, Sandra Trautmann, Gerd Geisslinger, Christian Münch, Simone Fulda, Irmgard Tegeder and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Peroxynitrite regulates ER stress-mediated CaJournal of translational medicine · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Nina MeyerExperimental Neurosurgery, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Lisa HenkelExperimental Neurosurgery, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Benedikt LinderExperimental Neurosurgery, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Svenja ZielkeExperimental Cancer Research in Pediatrics, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Georg TascherInstitute of Biochemistry II, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Sandra TrautmannInstitute of Clinical Pharmacology, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Gerd GeisslingerInstitute of Clinical Pharmacology, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Christian MünchInstitute of Biochemistry II, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.ORCID 0000-0003-3832-090X
Simone FuldaExperimental Cancer Research in Pediatrics, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Irmgard TegederInstitute of Clinical Pharmacology, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Donat KögelExperimental Neurosurgery, Goethe University Hospital Frankfurt/Main, Frankfurt, Germany.
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence suggests that induction of lethal macroautophagy/autophagy carries potential significance for the treatment of glioblastoma (GBM). In continuation of previous work, we demonstrate that pimozide and loperamide trigger an ATG5- and ATG7 (autophagy related 5 and 7)-dependent type of cell death that is significantly reduced with cathepsin inhibitors and the lipid reactive oxygen species (ROS) scavenger α-tocopherol in MZ-54 GBM cells. Global proteomic analysis after treatment with both drugs also revealed an increase of proteins related to lipid and cholesterol metabolic processes. These changes were accompanied by a massive accumulation of cholesterol and other lipids in the lysosomal compartment, indicative of impaired lipid transport/degradation. In line with these observations, pimozide and loperamide treatment were associated with a pronounced increase of bioactive sphingolipids including ceramides, glucosylceramides and sphingoid bases measured by targeted lipidomic analysis. Furthermore, pimozide and loperamide inhibited the activity of SMPD1/ASM (sphingomyelin phosphodiesterase 1) and promoted induction of lysosomal membrane permeabilization (LMP), as well as release of CTSB (cathepsin B) into the cytosol in MZ-54 wild-type (WT) cells. Whereas LMP and cell death were significantly attenuated in

Indexed as

AutophagyAutophagy-Related Protein 5Autophagy-Related Protein 7Brain NeoplasmsCathepsinsCell DeathCell Line, TumorCeramidesGene Knockout TechniquesGlioblastomaHumansLipid MetabolismLoperamideLysosomesPermeabilityPimozideATG5 protein, humanATG7 protein, humanAutophagy-Related Protein 5Autophagy-Related Protein 7CathepsinsCeramidesLoperamidePimozideProteomeSMPD1 protein, humanSphingomyelin PhosphodiesteraseAcid sphingomyelinaseautophagy-dependent cell deathbrain tumorscholesterol metabolismdrug repurposinger stresslysophagy

Identifiers

PMID33461384
PMCPMC8632287
OpenAlexW3122289558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.